Microbial, immune, metabolic perturbations by antibiotics (MIME study)
抗生素对微生物、免疫、代谢的干扰(MIME 研究)
基本信息
- 批准号:10159190
- 负责人:
- 金额:$ 34.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:18 year oldAcuteAdultAffectAftercareAmbulatory CareAmoxicillinAntibioticsBacteriaBloodCarbohydratesCellsChildClinicalClinical ProtocolsClinical TrialsCognitiveComplexDataData AnalysesDevelopmentDietDiffuseDisincentiveDoxycyclineEnergy MetabolismEvaluationExperimental Animal ModelFatty acid glycerol estersFecesFingerprintFunctional disorderGenesHormonalHourHumanHuman MicrobiomeHuman VolunteersHuman bodyImmuneImmune responseImmunityImmunologicsInformaticsInstitutional Review BoardsInstructionLeadLifeMeasurableMeasuresMetabolicMetabolic MarkerMetabolismModelingNational Institute of Allergy and Infectious DiseaseNatural ImmunityPerceptionPersonsPharmacologyPhysiciansPhysiologyPlasmaPlayPopulationRadarRandomized Clinical TrialsResidual stateResistanceRoleShapesSiteSleepSpecificitySpecimenTestingTetracyclinesTherapeuticTimeToxic effectUnited StatesUnited States National Institutes of HealthUrineadaptive immunitybacterial communitybeta-Lactamsclinical centerinsightmetagenomemicrobialmicrobiomemicrobiome compositionmicrobiotaside effectvolunteer
项目摘要
More than 250 million courses of antibiotics are prescribed annually in the ambulatory care setting in the
United States alone, including more than 40 million in children under 18 years of age. The perception that
antibiotic use has minimal attendant adverse side effects contributes to the over-utilization of antibiotics in
clinical circumstances when they are not strictly indicated. Thus, among physicians and the public alike,
since the use of antibiotics seems to be relatively free of toxicity, there appears to be no disincentive to
their use despite marginal perceived or measured benefit. We have learned much about the human
microbiome – the large, highly diverse, bacterial community that lives in and on us. The emerging view is of
profound life-long bidirectional interactions between our microbiota and our cells; in essence, our
microbiota are a central part of human physiology. Perturbations in the microbiota affect metabolic,
immune, and cognitive physiology in experimental animal models. When a person takes an antibiotic, the
antibiotic diffuses via the blood into all body compartments, selecting for resistance. We propose to
examine the effects of two commonly used antibiotics [a tetracycline (doxycycline) and a beta-lactam
(amoxicillin)] on human microbial populations and on metabolic and immune physiology, studying healthy
human volunteers in a randomized clinical trial at the NIH Clinical Center (CC). Our hypothesis is that in
addition to acutely perturbing the human microbiome, these agents will have measurable metabolic and
immunologic effects, with residual effects in the weeks that follow.
To test this hypothesis, in Aim 1, we will assess the effects of a brief therapeutic course of antibiotics
on microbiota and metagenome composition. After an initial evaluation period, antibiotics will be given
for seven days, and there will be a prolonged post-treatment evaluation. Specimens will be obtained from
multiple sites at each of 10 time-points in total, and used for estimating bacterial and fungal composition
and gene content. In Aim 2, we will assess the effects of the antibiotic course on immune
physiology. At each time point, blood, urine, and feces will be obtained to determine plasma and cellular
levels of markers of both innate and adaptive immunity. In Aim 3, we will assess the effects of the
antibiotic course on metabolic physiology. The obtained blood and urine specimens will be assessed
for markers of metabolic and hormonal physiology. In a subset of subjects, we will utilize the unique CC
Metabolic Chamber to quantify 24-hour energy expenditure and its components (sleeping, diet-induced,
and activity) and carbohydrate and fat utilizations. In addition to the primary data analyses, we will build an
informatic model integrating the temporal data to provide insight into the complex intertwined physiology
between microbiome and host. This project is an opportunity to perform comprehensive and integrated
evaluations of pharmacologic agents given to tens of millions of people every year. Careful analysis and
development of an integrated model to understand the pathophysiology of the perturbations may identify
the fingerprints of problems that had been below the radar.
RELEVANCE (See instructions):
Antibiotic use is extremely common in the United States, with over 250 million courses given each year.
Although antibiotics are largely safe, we believe that they play a role in shaping the composition of the
bacteria that normally live in and on the human body, and changing composition has the potential to
change immune responses, as well as lead to metabolic consequences. In a clinical trial, we will test
whether short courses of antibiotics given to healthy human adult volunteers will affect the microbiome
composition and perturb metabolism and immunity, and we will assess the magnitude, and specificity of the
perturbations, and how long they will last.
每年在室内护理环境中规定了超过2.5亿种抗生素课程
仅美国,包括18岁以下的儿童超过4000万。感知
抗生素使用的不利副作用最少有助于过度利用抗生素
临床情况并非严格指示。在医生和公众中,
由于抗生素的使用似乎相对不含毒性,因此似乎没有任何抑制
他们使用的目的地边际感知或测量的好处。我们学到了很多关于人的
微生物组 - 居住在我们身上的大型,高度多样的细菌社区。新兴观点是
我们的微生物群与我们的细胞之间的深刻终身双向相互作用;本质上,我们的
微生物群是人类生理学的核心部分。微生物群的扰动会影响代谢,
实验动物模型中的免疫和认知生理。当一个人服用抗生素时
抗生素通过血液扩散到所有身体室,选择抗性。我们建议
检查两种常用的抗生素[四环素(强力霉素)和β-内酰胺
(阿莫西林)]在人类微生物种群以及代谢和免疫生理学上,研究健康
在NIH临床中心(CC)的一项随机临床试验中,人类志愿者。我们的假设是
除了急性干扰人类微生物组,这些药物还将具有可测量的代谢和
免疫学效应,随后几周具有残留效应。
为了检验这一假设,在AIM 1中,我们将评估简短治疗过程的抗生素效果
关于微生物群和元基因组组成。初始评估期后,将给予抗生素
七天,将进行延长的治疗后评估。标本将从
总共10个时间点的多个位点,用于估计细菌和真菌组成
和基因含量。在AIM 2中,我们将评估抗生素课程对免疫的影响
生理。在每个时间点,将获得血液,尿液和粪便以确定血浆和细胞
先天和适应性免疫的标记水平。在AIM 3中,我们将评估
代谢生理学的抗生素课程。将评估获得的血液和尿液标本
用于代谢和荷尔蒙生理的标记。在主题的子集中,我们将利用唯一的CC
代谢室量化24小时能量消耗及其成分(睡眠,饮食引起的,
和活动)和碳水化合物和脂肪利用。除了主要数据分析外,我们还将建立一个
内容丰富的模型集成了临时数据,以洞悉复杂的相互交织的生理学
在微生物组和主机之间。该项目是执行全面和整合的机会
每年对数千万人提供的药物的评估。仔细的分析和
开发综合模型以了解扰动的病理生理学可能会识别
雷达以下的问题的指纹。
相关性(请参阅说明):
在美国,抗生素的使用极为普遍,每年提供超过2.5亿门课程。
尽管抗生素在很大程度上是安全的,但我们认为它们在塑造构图中发挥了作用
通常生活在人体上和人体上的细菌,而不断变化的组成有可能
改变免疫反应,并导致代谢后果。在临床试验中,我们将测试
对健康的人类成人志愿者提供的抗生素的简短课程是否会影响微生物组
组成和扰动代谢和免疫力,我们将评估
扰动,以及他们将持续多长时间。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARTIN J BLASER其他文献
MARTIN J BLASER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARTIN J BLASER', 18)}}的其他基金
Cohort and biomarkers for COVID-19 severity, natural history, and reinfection
COVID-19 严重程度、自然病程和再感染的队列和生物标志物
- 批准号:
10689118 - 财政年份:2021
- 资助金额:
$ 34.06万 - 项目类别:
Cohort and biomarkers for COVID-19 severity, natural history, and reinfection
COVID-19 严重程度、自然病程和再感染的队列和生物标志物
- 批准号:
10490891 - 财政年份:2021
- 资助金额:
$ 34.06万 - 项目类别:
Cohort and biomarkers for COVID-19 severity, natural history, and reinfection
COVID-19 严重程度、自然病程和再感染的队列和生物标志物
- 批准号:
10375868 - 财政年份:2021
- 资助金额:
$ 34.06万 - 项目类别:
Microbial, immune, metabolic perturbations by antibiotics (MIME study)
抗生素对微生物、免疫、代谢的干扰(MIME 研究)
- 批准号:
9923556 - 财政年份:2019
- 资助金额:
$ 34.06万 - 项目类别:
Microbial, immune, metabolic perturbations by antibiotics (MIME study)
抗生素对微生物、免疫、代谢的干扰(MIME 研究)
- 批准号:
9246429 - 财政年份:2016
- 资助金额:
$ 34.06万 - 项目类别:
Microbial, immune, metabolic perturbations by antibiotics (MIME study)
抗生素对微生物、免疫、代谢的干扰(MIME 研究)
- 批准号:
9037283 - 财政年份:2016
- 资助金额:
$ 34.06万 - 项目类别:
Disappearing gastrointestinal microbiota in epidemic obesity.
流行性肥胖症中胃肠道微生物群的消失。
- 批准号:
8780962 - 财政年份:2014
- 资助金额:
$ 34.06万 - 项目类别:
Mathematical Models of H. Pylori gastric colonization
幽门螺杆菌胃定植的数学模型
- 批准号:
8669633 - 财政年份:2013
- 资助金额:
$ 34.06万 - 项目类别:
Evaluation of the cutaneous microbiome in psoriasis
银屑病皮肤微生物群的评估
- 批准号:
8698894 - 财政年份:2013
- 资助金额:
$ 34.06万 - 项目类别:
相似国自然基金
去泛素化酶USP5调控P53通路在伴E2A-PBX1成人ALL的致病机制研究
- 批准号:81900151
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
核基质结合区蛋白SATB1调控CCR7抑制急性T淋巴细胞白血病中枢浸润的作用与机制
- 批准号:81870113
- 批准年份:2018
- 资助金额:55.0 万元
- 项目类别:面上项目
成人及儿童急性淋巴细胞白血病的基因组转录组生物信息学分析方法建立及数据分析
- 批准号:81570122
- 批准年份:2015
- 资助金额:60.0 万元
- 项目类别:面上项目
NR3C1基因突变在成人急性淋巴细胞白血病耐药与复发中的作用与机制研究
- 批准号:81470309
- 批准年份:2014
- 资助金额:75.0 万元
- 项目类别:面上项目
儿童和成人急性T淋巴细胞白血病中miRNA和转录因子共调控网络的差异性研究
- 批准号:31270885
- 批准年份:2012
- 资助金额:80.0 万元
- 项目类别:面上项目
相似海外基金
Racial disparities for the effects of parental marijuana use on youth marijuana and other substance use
父母吸食大麻对青少年吸食大麻和其他药物的影响的种族差异
- 批准号:
10593655 - 财政年份:2023
- 资助金额:
$ 34.06万 - 项目类别:
Effect of Medicaid Accountable Care Organizations on Behavioral Health Care Quality and Outcomes for Children
医疗补助责任护理组织对儿童行为保健质量和结果的影响
- 批准号:
10729117 - 财政年份:2023
- 资助金额:
$ 34.06万 - 项目类别:
The National Couples Health and Time Use Stress Biology Study (NCHAT-BIO): Biobehavioral Pathways to Population Health Disparities in Sexual Minorities
全国夫妻健康和时间使用压力生物学研究 (NCHAT-BIO):性别少数人口健康差异的生物行为途径
- 批准号:
10742339 - 财政年份:2023
- 资助金额:
$ 34.06万 - 项目类别:
Role of Lateral Habenula- Dorsal Raphe Circuit on MA-Induced Aversion
外侧缰核-中缝背侧回路对 MA 诱发厌恶的作用
- 批准号:
10601869 - 财政年份:2023
- 资助金额:
$ 34.06万 - 项目类别:
Mindfulness-Based Stress Reduction in Adolescents with Type 1 Diabetes
基于正念的 1 型糖尿病青少年减压
- 批准号:
10552006 - 财政年份:2022
- 资助金额:
$ 34.06万 - 项目类别: